Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 April 2018 Photo Supplied
Strong athletics team for USSA
The 800m athlete Rynardt van Rensburg is one of several Kovsies who is expected to win a gold medal at the national student champs this weekend.

With three Olympians in their midst and a number of athletes who are serious contenders for a first place, the Kovsie athletics team looks set to make a statement at the 2018 national student champs.

The University Sport South Africa (USSA) event takes place from Friday 27 April to Sunday 29 April 2018 in Sasolburg.

Kovsies finished fifth at last year’s USSA with four gold, four silver and four bronze medals.

There were initial concerns the team might be weakened by the loss of five of their top athletes who are competing at the CAA Southern Region Youth and Junior Championships that is also taking place this weekend in Boksburg.  

Luckily for Tsebo Matsoso (200m), Pakiso Mthembu (5 000m), Tyler Beling (1 500 m) and Lara Orrock (3 000m steeplechase), their events on the USSA programme are only scheduled for Sunday which will allow them to participate in both meetings. Michaéla Wright (SA U20 long jump champion) won’t be able to compete in Sasolburg either. 

Beling and Orrock, along with Ts’epang Sello (800m and 1 500m), Kesa Molotsane (5 000m and 10 000m), Lynique Beneke (long jump), Carien Sander (400m), Hendrik Maartens (200m), Sefako Mokhosoa (triple jump), Mthembi Chauque (20km walk), Peter Makgato (long jump) and Rynardt van Rensburg (800m and 1 500m) are all realistic gold medal contestants.

Van Rensburg, Sello and Beneke have all been to the Olympic Games in 2016. Van Rensburg’s 1:46.15 last month in the 800m currently ranks 21st among the best times in 2018 on the global stage.

Beneke defended her national crown last month with a winning distance of 6.22m and Sello came very close to running her personal best in the 800m at the Commonwealth Games.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept